Seed Innovations Limited Portfolio Company Update: Northern Leaf Limited
12 Juni 2023 - 9:07AM
RNS Non-Regulatory
TIDMSEED
Seed Innovations Limited
12 June 2023
12 June 2023
SEED Innovations Limited
("SEED" or the "Company")
Portfolio Company Update: Northern Leaf Limited
Northern Leaf Limited Awarded GMP Accreditation
SEED Innovations Ltd, the AIM-quoted Company investing in
fast-growing and industry-leading businesses with a focus on the
medical cannabis, health and wellness space, is pleased to announce
an update from portfolio company Northern Leaf Limited ("Northern
Leaf"), a Jersey based medical cannabis producer. Northern Leaf has
been awarded Good Manufacturing Practices ("GMP") accreditation for
its flower product as an active pharmaceutical ingredient. The
accreditation is from the UK's Medicines and Healthcare Products
Regulatory Agency ("MHRA"), and a key regulatory milestone for the
company to export its products to the European Union ("EU").
The Company owns 1,236,331 ordinary shares in Northern Leaf
representing 2.2% of Northern Leaf's issued share capital.
Commenting on the accreditation, CEO at Northern Leaf, Don
Perrott, said: "GMP accreditation is an extremely rigorous, costly
and multi-year process. Receiving this accreditation from the MHRA,
who is seen as the gold standard in the industry, is a significant
achievement for Northern Leaf. It's the strongest possible
endorsement of our people, processes and product as we seek to
develop high quality cannabis-based medicines for the benefit of
patients across the EU and internationally."
Ed McDermott, CEO at SEED, commented: "I am pleased to share
Northern Leaf's latest development with SEED's shareholders. Along
with its already granted Home Office permissions, the GMP
accreditation puts Northern Leaf in a strong position to export
medical-grade cannabis products across the rapidly growing EU
markets. With Northern Leaf focused on becoming a key player in the
European medical cannabis supply chain , I look forward to bringing
further updates to the market in due course."
- Ends -
For further information on the Company please visit: www.seedinnovations.com or contact:
Ed McDermott SEED Innovations E: info@seedinnovations.co
Lance de Ltd
Jersey
James Biddle Beaumont Cornish T: (0)20 7628 3396
Roland Cornish Limited,
Nomad
----------------------- -------------------------------
Isabella Shard Capital Partners T: (0)20 7186 9927
Pierre LLP
Damon Heath Broker
----------------------- -------------------------------
Catherine St Brides Partners E: seed@stbridespartners.co.uk
Leftley Ltd,
Isabelle Financial PR
Morris
Max Bennett
----------------------- -------------------------------
Notes to Editors
Seed Innovations Ltd
SEED Innovations is an AIM quoted investment company focused
primarily on disruptive high growth life sciences and technology
businesses particularly within the medical cannabis arena. The
Company's strategy is to identify early-stage opportunities that
have an upcoming investment catalyst and grow its portfolio in
terms of value whilst limiting the number of investee companies to
a level where relevant time can be devoted to each.
About Northern Leaf Limited
Northern Leaf is a medical cannabis cultivator based in Jersey
that, in December 2020, was granted the first UK commercial high
THC medical cannabis license since UK based GW Pharmaceuticals
(NASDAQ:GWPH) in 1998. The Company is leading the development of a
new industry for the British Isles, creating centres of excellence,
using state-of-the-art tracking systems and robust policies and
procedures to ensure the highest levels of quality from seed to
sale.
With a secure operational facility already built in Jersey where
the favourable climate and sunshine hours contribute to a
comparably lower cultivation cost, Northern Leaf will grow
commercial quantities of medical cannabis for the rapidly growing
European market, including the key markets of the UK, Germany, and
Israel. For more information about Northern Leaf, please visit
https://www.northern-leaf.com/.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAGZGMVNZKGFZG
(END) Dow Jones Newswires
June 12, 2023 03:07 ET (07:07 GMT)
Kuala Innov (LSE:KUL)
Historical Stock Chart
Von Okt 2024 bis Nov 2024
Kuala Innov (LSE:KUL)
Historical Stock Chart
Von Nov 2023 bis Nov 2024